All the Drug Class Drugs
Parathyroid hormone analogue. Teriparatide 250 mcg/ml. PRE-FILL. PEN (sol. for S.C. inj.):1,3. The usual. dose one S.C. inj. dly., in the thigh or lower abdomen. See lit.
Tmt . of postmenopaus. women with osteoporosis at high risk for frac., defined as a history of osteoporotic frac., multiple risk fact. for frac., or pts. who have failed or are intoler. to other available osteoporosis ther. In postmenopaus. women with osteoporosis, Teriparatide increas. BMD reduces the risk of vertebral and nonvertebral frac.
Indicated to incr. bone mass in men with prim. or hypogonadal osteoporosis at high risk for frac., defined as a history of osteoporotic frac., multiple risk fact. for frac., or pts. who have failed or are intoler.to other available osteoporosis ther.
Tmt. of men & women with osteoporosis associat. with sustained system. glucocorticoid ther. (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for frac., defined as a history of osteoporotic frac., multiple risk fact. for frac., or pts. who have failed or are intoler.to other available osteoporosis ther.
C/I: Hypersens.
Preg., lact.
Pts. with Paget’s dis., hypercalcem., metabol. bone dis., bone tumors.
Pts. that had underwent radiation ther. for the bones.
Severe renal impair.
Child. or a young pt. in the grow. stage.
Hyperparathyroidism.
Parathyroid hormone analogue. Teriparatide 20 mcg/dose. Sol. for inj.
CARTRIDGE: 1×2.4 ml
STARTER BOX: (CARTRIDGE 2.4 ml×1 + PEN ×1)
20 mcg SC once/d .
tmt. of postmenopausal women with osteopor. at high risk for fract., (hist. of osteoporotic fract., multiple risk factors for fract., or pts who have failed or are intol. to other available osteopor. ther.) In these pts., this drug incr. bone mineral density (BMD), reduc. risk of vertebral and non-vertebr. fracts.
to incr. bone mass in men with prim. or hypogonadal osteopor. at high risk for fract., (hist. of osteoporotic fract., multiple risk factors for fract., or pts who have failed or are intol. to other available osteopor. ther.)
tmt. of men and women with osteopor. assoc. with sust. syst. glucocorticoid therapy (daily dosage equiv. to 5 mg or greater of prednisone) at high risk for fract., (hist. of osteoporot. fract., multiple risk factors for fract., or pts. who have failed or are intol. to other available osteopor. ther.)
C/I: Hypersens. Hypersens. react. have incl. angioedema and anaphylaxis.
